Latisse Ophthalmic Solution (Bimatoprost 0.03%)

Latisse Ophthalmic Solution is a bimatoprost 0.03% treatment for adults with eyelash hypotrichosis, meaning eyelashes that are inadequate, thin, or sparse. Its defining feature is the route of use: the solution is applied along the skin at the base of the upper eyelashes rather than instilled into the eye as a glaucoma drop. That distinction matters more than the fact that some eye-pressure medicines also contain bimatoprost.

For someone comparing products, Latisse Ophthalmic Solution is the relevant choice when the intended treatment is upper-eyelash growth and a health professional considers bimatoprost appropriate. Bimatoprost or another prostaglandin analogue formulated and labelled for glaucoma should not be treated as a do-it-yourself substitute. Conversely, Latisse is not a replacement for prescribed treatment of glaucoma or elevated intraocular pressure.

Latisse Ophthalmic Solution compared with other eye-treatment options

The comparisons below distinguish products by active ingredient, intended use, route, and practical administration. They are not a ranking of one universal best option: the appropriate choice depends first on whether the goal is eyelash treatment or control of pressure inside the eye.

Lumigan and Latisse Ophthalmic Solution contain the same active ingredient, bimatoprost, but they are used for different purposes. Lumigan is administered into the eye to reduce elevated intraocular pressure, whereas Latisse is applied topically to the upper eyelid margin to promote eyelash growth. Their directions, packaging components, and clinical purpose should therefore be checked separately rather than inferred from the shared ingredient.

Xalatan contains latanoprost, while travoprost products such as Travatan Z contain travoprost. These medicines belong to the same broad prostaglandin-analogue class as bimatoprost, but they do not contain the same active ingredient and are intended for eye-pressure treatment. A person already using Lumigan, Xalatan, Travatan Z, or another medicine for glaucoma or elevated eye pressure should discuss Latisse with a doctor or pharmacist before adding it.

Generic bimatoprost ophthalmic solutions may also be available for intraocular use. A matching ingredient name or concentration does not establish that another solution has the same authorized use, administration method, applicators, or product information as Latisse. Substitution should be discussed with a prescriber or pharmacist rather than based on the ingredient alone.

Why upper-eyelid application matters

Latisse Ophthalmic Solution is applied to the upper eyelid margin with a fresh, sterile, single-use applicator intended for this method. It is not applied to the lower lash line and is not routinely placed directly into the eye. Using a separate applicator for each eye helps reduce contamination and prevents an applicator used on one eyelid from being transferred to the other.

The targeted route also helps limit solution spreading beyond the intended lash line. Excess liquid should be blotted from surrounding skin because repeated contact outside the application area can cause unwanted hair growth or skin darkening. If solution accidentally enters the eye, it generally does not need to be rinsed out, but temporary irritation or blurred vision may occur.

Our product information identifies Allergan Pharmaceuticals Ireland as the manufacturer associated with this offer. The active ingredient is bimatoprost, the dosage form is an ophthalmic solution, and the offered strength is 0.03%.

How bimatoprost affects eyelash growth

Eyelashes move through active growth, transition, and resting phases. Bimatoprost is thought to increase the proportion of hairs in the active growth phase and extend that phase, allowing changes in eyelash length, thickness, and darkness to develop gradually. It does not produce an immediate result after one or two applications.

Consistent use is important, but individual results and timing vary. Applying more than directed or using the solution more than once daily is not expected to accelerate growth and may increase unwanted effects. If treatment is discontinued, the eyelashes generally return gradually toward their previous appearance because bimatoprost influences the ongoing hair cycle rather than creating a permanent structural change.

Package options and value

We offer Latisse Ophthalmic Solution 0.03% in packages of one, two, three, four, or six bottles. A single-bottle package may suit someone beginning treatment or following a shorter plan established with a health professional. Multi-bottle packages may be more practical for someone expecting to continue treatment and wishing to reduce the risk of running out between orders.

Package value should be assessed using the current total price, bottle count, and per-bottle cost rather than assuming that the largest package is automatically best. The comparison below shows the values for the options we offer. Our checkout remains authoritative for the final price, current-currency display, and any shipping eligibility.

Canadian prescription status and our ordering policy

Latisse 0.03% is an authorized prescription drug product in Canada. Its current Drug Identification Number, marketed package, and official product information can be checked through Health Canada's Drug Product Database. This national classification is separate from provincial and territorial differences in drug coverage, pharmacy regulation, and benefit plans.

Our ordering policy for this product does not require customers to upload, fax, or otherwise provide a prescription for us to accept an order. That does not change the medicine's prescription status in Canada. It simply describes our checkout requirement for this listing. We do not present our ordering policy as a Health Canada reclassification or as proof that Latisse is suitable for a particular person.

If you have questions before ordering, our support team is available 24/7 by email, online chat, and phone, and pharmacist support is available. A pharmacist or doctor should assess questions about personal suitability, eye conditions, pregnancy, breastfeeding, concurrent medicines, or unexpected symptoms.

How to apply Latisse

• Apply it once daily in the evening unless a health professional has given different instructions based on the official product information.
• Remove makeup, cleanse the face and eyelids, and remove contact lenses before application. Wait at least 15 minutes before reinserting contact lenses.
• Place the directed amount of solution on a fresh sterile applicator and draw it along the skin at the base of the upper eyelashes only.
• Use a separate new applicator for the other eye. Do not reuse an applicator between eyes or on another night.
• Blot excess solution from surrounding skin, avoid the lower lash line, and dispose of each applicator after use.

Apply the product consistently to both upper eyelid margins unless a health professional has advised otherwise. Uneven application can contribute to differences in eyelash appearance. Do not allow the bottle tip to touch fingers, an applicator, the eyelid, or another surface because contact can contaminate the solution.

Side effects, interactions, and storage

Effects most often involve the eyes, eyelids, or surrounding skin. Mild redness, itching, dryness, or irritation can occur. Eyelid skin may become darker, and hair may grow on skin repeatedly exposed outside the intended application area. Increased brown pigmentation of the iris is less common with eyelid-margin use but may be permanent if it occurs, particularly when solution repeatedly reaches the eye.

• Stop and seek advice for persistent eye pain, marked redness, swelling, discharge, a substantial vision change, or signs of an allergic reaction.
• Wait until vision is clear before driving or operating machinery if accidental eye exposure causes temporary blurred vision.
• Tell a doctor or pharmacist about Lumigan or any other glaucoma or eye-pressure treatment because adding Latisse may affect the response to prostaglandin medicines or complicate monitoring.
• Ask for advice if you have active eye inflammation, a history of macular swelling, recent eye surgery, or an ongoing condition affecting the eyelids or eye surface.
• Store the solution at 2°C to 25°C, keep the bottle closed between uses, and protect it from inappropriate heat or freezing.

This overview does not replace the Canadian product monograph or individual clinical advice. Suspected adverse reactions may be reported to Health Canada through the Canada Vigilance Program.

Who should avoid Latisse or seek advice first

Latisse is intended for adults. Its safety and effectiveness have not been established in children, and the Canadian authorization does not include a pediatric indication. Anyone with a known allergy to bimatoprost or another ingredient in the solution should not use it.

Human pregnancy data are inadequate, so use during pregnancy requires an individual assessment of whether the expected benefit justifies the potential risk. It is not known whether bimatoprost is excreted in human milk, and caution is advised during breastfeeding. Diabetes alone is not listed as a product-specific contraindication, but existing eye disease or eye-pressure treatment remains relevant to the decision.

People who wear contact lenses should follow the removal and reinsertion interval because the preservative may be absorbed by soft lenses. Anyone receiving ongoing eye care should ensure that the eye-care professional knows about both Latisse and any other ophthalmic products being used.

Where to buy Latisse Ophthalmic Solution in Canada

If you plan to buy Latisse Ophthalmic Solution online, compare the offered bottle count with the expected duration of your treatment plan and the time needed for delivery. Our listing displays the package options and current price, while our checkout confirms the final amount and applicable shipping terms.

We accept Visa, Mastercard, American Express, Bitcoin, and USDT for this offer. Customers deciding where to buy Latisse Ophthalmic Solution in Canada should also consider the distinction between Canadian prescription classification and an individual seller's ordering requirements. Our policy does not require a prescription for this product, but professional advice remains appropriate when suitability or safe use is uncertain.

We have operated since 2010 and provide support before and after ordering through email, online chat, and phone. These operational services do not replace diagnosis, prescribing, or ongoing care from a doctor, optometrist, ophthalmologist, or local pharmacist.

Shipping and receiving orders across Canada

We offer tracked Express shipping and untracked Standard shipping. The delivery windows shown for Canadian destinations are estimates rather than guarantees. Distance, destination, carrier operations, severe weather, and service conditions can affect when an order reaches an urban, rural, northern, or remote address.

Canada's long distances and seasonal temperature extremes make prompt collection important. Once we show an order as delivered, bring it indoors as soon as reasonably possible rather than leaving it in a sun-exposed mailbox, hot vehicle, outdoor parcel box, or freezing community mail compartment. The product should be kept within its stated storage range of 2°C to 25°C.

Before completing our checkout, confirm the destination address and postal code and select the shipping method appropriate for your timing needs. Tracking is available with our Express option but not with our Standard option. Our checkout shows the current shipping charge and any applicable threshold-based shipping terms.